查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018636

腔內縫合器材市場：按產品類型、技術、應用、最終用戶和分銷管道分類的全球市場預測，2026-2032年

Endoluminal Suturing Devices Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，管腔縫合器材市場價值將達到 547.3 億美元，到 2026 年將成長至 618.3 億美元，到 2032 年將達到 1,309 億美元，複合年成長率為 13.26%。

主要市場統計數據
基準年 2025 547.3億美元
預計年份：2026年 618.3億美元
預測年份 2032 1309億美元
複合年成長率 (%) 13.26%

微創治療中腔內縫合裝置的臨床作用、技術進步及其對醫療機構的影響的策略概述

腔內縫合裝置已迅速成為微創胃腸道疾病和肥胖症治療中至關重要的基礎技術。這些系統無需開放性手術即可實現精準的組織通路建立、缺損閉合和管腔再形成，從而減少手術創傷並加速患者康復。裝置人體工學、材料科學和影像相容性方面的進步拓展了其適應症，使臨床醫生能夠將縫合技術融入常規內視鏡手術流程中。

技術融合、不斷擴大的臨床應用案例以及醫療服務模式的變革正在重新定義腔內縫合平台的競爭格局。

在技​​術融合、臨床適應症拓展和醫療服務模式演變的推動下，腔內縫合領域正經歷著一場變革。除了精密的手動操作平台外，自動化和機器人技術也正在興起，提高了手術操作的一致性，並縮短了新用戶的學習曲線。這些技術進步與改進的影像技術和內視鏡附件相輔相成，使得更複雜的重組和治療性介入成為可能。

2025 年美國累積關稅對腰椎縫合器械相關人員的採購決策、定價策略和業務永續營運產生了哪些影響？

美國將於2025年開始實施累積關稅，這為醫療設備製造商和供應商的採購決策、供應鏈規劃和定價策略帶來了新的不確定性。關稅帶來的成本壓力加劇了對籌資策略的審視，許多供應商正在重新評估海外製造與國內或近岸生產之間的平衡。因此，各組織正在加速供應商多元化，以降低依賴單一供應商的風險，同時也正在探索能夠縮短前置作業時間、降低物流複雜性的本地生產方案。

確定每種產品類型、技術、臨床應用、醫療保健提供者環境和通路的採用促進因素，並制定商業策略。

細分市場分析揭示了不同產品類型、技術、應用、最終用戶和分銷管道的採納和價值創造因素各不相同。一次性系統和可重複使用系統的選擇反映了一次性使用的便利性和重複性操作的成本效益之間的權衡。一次性平台減輕了消毒負擔和交叉感染風險，而當操作次數和消毒基礎設施能夠覆蓋折舊成本時，可重複使用平台則更具吸引力。從技術角度來看，有自動化和手動兩種方法。自動化平台可實現標準化部署並縮短操作人員培訓時間，而手動系統則保持了柔軟性，並降低了重視客製化和手動操作的機構的資本投資成本。

美洲、歐洲、中東和非洲以及亞太地區的區域狀況和商業化需求決定了實施策略。

區域趨勢造就了獨特的監管、報銷和營運環境，這些都會影響醫療器材的普及和商業化。在美洲，先進的內視鏡中心集中分佈，臨床試驗網路健全，且支付方重視安全性和提案明確的診療方案，這些因素共同推動了醫療器材的臨床應用。因此，製造商通常會優先考慮與臨床機構建立夥伴關係，在主要大都會圈市場進行強力的實證醫學研究和有針對性的培訓項目，以加快醫療器材在醫院和門診中心的普及速度。

在腔內縫合生態系統中，競爭性合作、臨床夥伴關係策略和技術主導的差異化如何決定領導地位？

醫療器材開發商、臨床創新者和服務供應商之間的競爭與合作動態在產業發展中發揮核心作用。領先企業致力於產品迭代改進、拓展培訓體係以及進行上市後監測，以驗證產品的安全性和手術有效性。與關鍵意見領袖 (KOL) 和學術機構建立策略合作夥伴關係是檢驗新適應症、改善使用者介面和耗材設計的核心機制。

為醫療設備開發商和醫療保健提供者制定可操作的策略重點，以加速部署、增強韌性並展現永續的臨床和經濟價值。

產業領導者應採取多管齊下的策略，協調產品開發、臨床證據產生和產品上市時間。首先，應優先考慮人性化的設計，降低手術複雜性和訓練時間，同時將直覺的器械人體工學設計與增強的可視化和設備回饋相結合。其次，應投資於有針對性的臨床試驗和真實世界證據（RWE）項目，重點關注手術安全性、療效比較以及因減少併發症和縮短恢復時間而降低的後續成本。

採用綜合調查方法，結合專家訪談、臨床證據整合以及監管和供應鏈分析，以確保研究的嚴謹性和實際相關性。

本分析的研究基於三角測量法，該方法結合了專家訪談、同行評審的臨床文獻整合以及對監管和採購框架的結構化分析。我們訪問了執業內視鏡醫師、外科主任、採購負責人和高級產品開發人員，以了解實際操作、訓練考量和商業性限制。臨床文獻和手術結果的研究有助於我們加深對安全性特徵和手術能力比較的理解。

在瞬息萬變的環境中，整合證據並為公司和醫療保健提供者提供策略見解，對於實現臨床意義和長期商業性競爭力至關重要。

腔內縫合器材正處於轉折點，技術成熟、臨床應用不斷拓展以及商業性格局的轉變交匯融合，為以價值主導的創新創造了巨大機會。持續成功取決於器械性能與手術流程的匹配、建立可靠的臨床證據以及製定靈活的商業化策略，以適應不同地區的監管和採購差異。尤其鑑於近期的貿易政策趨勢，供應鏈韌性和嚴謹的成本建模已成為商業規劃的核心要素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：腔內縫合器材市場：依產品類型分類

  • 免洗系統
  • 可重複使用系統

第9章：腔內縫合器材市場：依技術分類

  • 自動的
  • 手動的

第10章 腔內縫合器材市場：依應用領域分類

  • 內視鏡黏膜切除術
  • 內視鏡袖狀胃切除術
  • 內視鏡黏膜下剝離術
  • 口腔內視鏡肌切開術

第11章 腔內縫合器材市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 大學醫院
    • 當地醫院
  • 專科診所

第12章 腔內縫合器械市場：依分銷管道分類

  • 直銷
  • 銷售代理
    • 增值轉售商
    • 批發商

第13章 腔內縫合器材市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 腔內縫合器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 腔內縫合器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國腔內縫合器材市場

第17章：中國腔內縫合器材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Apollo Endosurgery, Inc.
  • Aponos Medical LLC
  • Becton, Dickinson company
  • Boston Scientific Corporation
  • Catholic Health Initiatives
  • Cook Medical LLC
  • EndoTools Therapeutics SA
  • Fujifilm Holdings Corporation
  • HOYA Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • STERIS plc
  • Stryker Corporation
Product Code: MRR-221461476DBA

The Endoluminal Suturing Devices Market was valued at USD 54.73 billion in 2025 and is projected to grow to USD 61.83 billion in 2026, with a CAGR of 13.26%, reaching USD 130.90 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 54.73 billion
Estimated Year [2026] USD 61.83 billion
Forecast Year [2032] USD 130.90 billion
CAGR (%) 13.26%

A strategic primer on the clinical role, technological advances, and institutional implications of endoluminal suturing devices in minimally invasive care

Endoluminal suturing devices have rapidly established themselves as a critical enabling technology for minimally invasive gastrointestinal and bariatric interventions. These systems permit precise tissue approximation, defect closure, and lumen reshaping without open surgery, thereby reducing procedural trauma and supporting accelerated patient recovery. Advances in device ergonomics, material science, and imaging compatibility have expanded procedural indications and allowed clinicians to integrate suturing into routine endoscopic workflows.

Clinicians now rely on both automated and manual platforms to execute complex therapeutic interventions in confined anatomical corridors. These platforms are designed to balance ease of use with procedural flexibility, enabling adoption across a spectrum of clinical settings from ambulatory surgical centers to tertiary academic hospitals. Alongside clinical adoption, manufacturers are navigating regulatory pathways, sterility and reusability debates, and evolving payer considerations. Consequently, strategic commercialization demands a nuanced understanding of clinical evidence, reimbursement dynamics, and institutional purchasing behavior.

As the technology landscape matures, collaboration between device makers, endoscopists, and healthcare systems is deepening. This collaborative environment fosters iterative improvements in device performance and training protocols. Ultimately, the technology's value proposition rests on demonstrated clinical outcomes, streamlined workflows, and measurable benefits in patient throughput and resource utilization.

How technological convergence, broadened clinical use cases, and shifting care delivery models are redefining the competitive landscape for endoluminal suturing platforms

The endoluminal suturing landscape is undergoing transformative shifts driven by technological convergence, expanded clinical indications, and evolving care delivery models. Automation and robotics are appearing alongside refined manual platforms, enabling greater procedural consistency and shortening learning curves for new users. These technological transitions are complemented by improved imaging and endoscopic accessories that enable more complex reconstruction and therapeutic interventions.

Concurrently, the clinical application set is broadening beyond traditional mucosal defect closure to include primary interventions for obesity, functional disorders, and complex resections. Adoption is influenced by outcomes data demonstrating reduced complications and faster recovery, while educational initiatives and proctoring programs support safe dissemination of advanced techniques. In parallel, cost containment pressures and capacity constraints within hospitals are accelerating the migration of select procedures to ambulatory surgical centers and specialty clinics, thereby reshaping device procurement channels and service line economics.

Supply chain resilience and manufacturing innovation are also reshaping the landscape. Manufacturers are prioritizing scalable sterilization strategies and modular designs to balance disposable convenience with sustainability considerations. Taken together, these shifts create a dynamic competitive environment where clinical performance, ease of integration, and total procedural value determine long-term success.

Assessing how 2025 cumulative United States tariffs reshaped sourcing decisions, pricing strategies, and operational resilience for endoluminal suturing device stakeholders

The imposition of cumulative tariffs in the United States during 2025 has introduced a new variable into procurement decisions, supply chain planning, and pricing strategies for medical device manufacturers and providers. Tariff-related cost pressures have amplified scrutiny of sourcing strategies, with many suppliers reassessing the balance between overseas manufacturing and domestic or nearshore production. As a consequence, organizations are accelerating supplier diversification to mitigate the risk of single-source exposures while also exploring localization options that can shorten lead times and reduce logistical complexity.

Providers and manufacturers have responded by increasing collaboration on procurement contracts and exploring alternative distribution arrangements to absorb or redistribute tariff impacts. Some suppliers are restructuring their product portfolios to emphasize higher-margin, differentiated offerings that can better withstand incremental cost pressures. Meanwhile, clinical teams are prioritizing devices that deliver clear procedural efficiencies and demonstrable reductions in downstream resource utilization to justify adjusted pricing.

In addition to direct cost implications, tariffs have affected strategic timing for new product introductions and global launch sequencing. Regulatory entry strategies and inventory management practices have been revised to accommodate potential trade policy volatility. Ultimately, the imposed tariffs have emphasized the importance of flexible supply chains, transparent cost modeling, and proactive commercial strategies to maintain access and manage unit economics in a shifting trade environment.

Uncovering differentiated adoption drivers across product types, technologies, clinical applications, provider settings, and distribution pathways shaping commercial strategy

Segmentation analysis reveals differentiated drivers of adoption and value capture across product type, technology, application, end user, and distribution channel. Product type choices between disposable systems and reusable systems reflect a trade-off between single-use convenience and cost-efficiency over repeated procedures; disposable platforms reduce sterilization burden and cross-contamination risk while reusable platforms appeal where procedural volumes and sterilization infrastructure support amortization. Technology divides into automated and manual approaches, with automated platforms promising standardized deployment and potentially shorter operator training pathways, while manual systems retain flexibility and lower capital intensity for centers that prioritize customization and tactile control.

Application-specific dynamics influence product selection and training priorities. Procedures such as endoscopic mucosal resection and endoscopic submucosal dissection demand tactile precision for defect closure, whereas endoscopic sleeve gastroplasty and peroral endoscopic myotomy require sustained tissue manipulation and platform stability. End user segmentation highlights distinct purchasing logics across ambulatory surgical centers, hospitals, and specialty clinics; ambulatory centers prize turn-key systems that minimize turnaround time, specialty clinics focus on procedural throughput and targeted capabilities, and hospitals-both academic and community-balance clinical versatility with institutional procurement cycles and budgetary constraints. Distribution channel strategies vary between direct sales and distributor engagement, with value-added resellers and wholesalers playing differentiated roles in clinical training, consumable replenishment, and regional service coverage. These segmentation dynamics collectively shape product development priorities, commercial outreach, and support models for successful market penetration.

Comparative regional realities and commercialization imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping adoption strategies

Regional dynamics present distinct regulatory, reimbursement, and operational ecosystems that influence device adoption and commercialization. In the Americas, clinical adoption is driven by the concentration of advanced endoscopic centers, active clinical trial networks, and payer systems that reward procedures with clear value propositions in safety and efficiency. As a result, manufacturers often prioritize clinical partnerships, robust evidence generation, and targeted training programs to accelerate hospital and ambulatory center adoption curves across major metropolitan markets.

In Europe, Middle East & Africa, regulatory harmonization, heterogeneous reimbursement environments, and varying levels of healthcare infrastructure create a layered adoption landscape. Manufacturers must navigate national approval processes, align evidence packages to diversified payer criteria, and adapt commercial models to serve both advanced tertiary care centers and emerging specialty practices. Investment in local training, service capability, and distributor partnerships is particularly critical for regions where centralized procurement and tendering processes prevail.

The Asia-Pacific region exhibits rapid procedural uptake in several urban hubs, supported by high patient volumes and increasing investment in minimally invasive care. However, pricing sensitivity and diverse healthcare delivery models require flexible product configurations and distribution approaches. Across all regions, successful regional strategies combine clinical evidence, stakeholder education, and supply chain adaptability to address local regulatory and reimbursement realities while enabling scalable commercialization.

How competitive collaboration, clinical partnership strategies, and technology-driven differentiation are determining leadership in the endoluminal suturing ecosystem

Competitive and collaborative dynamics among device developers, clinical innovators, and service providers are central to the industry's evolution. Leading industry participants are investing in iterative product improvements, expanded training ecosystems, and post-market surveillance to demonstrate safety and procedural efficacy. Strategic collaborations with key opinion leaders and academic centers have become a core mechanism for validating novel indications and for refining user interfaces and consumable designs.

Partnerships between manufacturers and distributors are also evolving to include educational services, bundled support offerings, and shared inventory management to improve product availability and reduce clinical downtime. At the same time, new entrants focused on automation and digital integration are driving expectations for software-enabled procedural guidance and data capture, which in turn raises considerations around interoperability, cybersecurity, and regulatory compliance. Strategic M&A activity and licensing arrangements remain important pathways to access complementary technologies, extend geographic reach, and secure talent in engineering and clinical affairs.

Given these dynamics, competitive advantage accrues to organizations that combine rigorous clinical evidence, adaptable commercial models, and resilient manufacturing processes. Stakeholders who align device innovation with provider workflows and post-procedural outcomes will be best positioned to influence adoption trajectories and realize durable clinical and commercial impact.

Actionable strategic priorities for device developers and healthcare providers to accelerate adoption, build resilience, and demonstrate sustained clinical and economic value

Industry leaders should pursue a multi-pronged strategy that aligns product development, clinical evidence generation, and go-to-market execution. First, prioritize human-centered design to reduce procedural complexity and training time, pairing intuitive instrument ergonomics with enhanced visualization and device feedback. Next, invest in targeted clinical studies and real-world evidence programs that emphasize procedural safety, comparative effectiveness, and downstream cost offsets related to reduced complications and shortened recovery times.

Simultaneously, strengthen supply chain resilience through diversified sourcing, consideration of nearshoring for critical components, and rigorous supplier qualification processes. Commercially, adopt flexible distribution models that combine direct engagement in high-volume centers with distributor-led reach in fragmented regions, and provide comprehensive training and service bundles to lower barriers to adoption. In light of tariffs and trade uncertainty, implement transparent cost modeling and contingency plans that allow for agile pricing and contract renegotiations.

Finally, cultivate partnerships with procedural leaders and healthcare systems to co-develop training curricula and post-market registries that validate performance across varied care settings. By executing these integrated actions, organizations can accelerate adoption, sustain product differentiation, and demonstrate meaningful value to both clinical teams and institutional purchasers.

An integrated research methodology combining expert interviews, clinical evidence synthesis, and regulatory and supply chain analysis to ensure rigor and practical relevance

The research underpinning this analysis draws on a triangulated methodology combining expert interviews, peer-reviewed clinical literature synthesis, and structured analysis of regulatory and procurement frameworks. Interviews were conducted with practicing endoscopists, surgical leaders, procurement officers, and senior product developers to capture operational realities, training considerations, and commercial constraints. Clinical literature and procedural outcome studies informed understanding of safety profiles and comparative procedural capabilities.

Regulatory and reimbursement landscapes were reviewed using primary government and payer documentation, ensuring regional specificities were incorporated. Distribution and supply chain practices were assessed through discussions with commercial leaders and distributors, supplemented by publicly available company disclosures and product labeling information to validate claims about device features and intended use. Attention was paid to methodological transparency, with assumptions and data gaps explicitly identified for readers who require deeper drill-downs.

Quality control procedures included cross-validation of interview findings with published clinical evidence and iterative internal review by subject matter experts to ensure the analysis reflects operational realities and contemporary regulatory considerations. This blended approach delivers a practical and defensible foundation for the insights and recommendations presented.

Synthesis of evidence and strategic implications for companies and providers to capture clinical relevance and long-term commercial advantage in the evolving landscape

Endoluminal suturing devices stand at an inflection point where technological maturity, expanding clinical applications, and shifting commercial dynamics intersect to create significant opportunity for value-driven innovation. Sustained success will depend on aligning device performance with procedural workflows, building robust clinical evidence, and deploying flexible commercialization strategies that respond to regional regulatory and procurement differences. Supply chain resilience and thoughtful cost modeling are now core components of commercial planning, particularly in light of recent trade policy developments.

As care shifts toward minimally invasive and ambulatory settings, the devices that deliver procedural efficiency, reproducibility, and demonstrable patient benefit will command preference among providers. Strategic collaborations between manufacturers, clinical leaders, and healthcare systems will be essential to validate new indications and accelerate safe adoption. Ultimately, organizations that prioritize human-centered design, rigorous outcomes measurement, and adaptable go-to-market execution will be best positioned to capture clinical relevance and long-term commercial success in this evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoluminal Suturing Devices Market, by Product Type

  • 8.1. Disposable Systems
  • 8.2. Reusable Systems

9. Endoluminal Suturing Devices Market, by Technology

  • 9.1. Automated
  • 9.2. Manual

10. Endoluminal Suturing Devices Market, by Application

  • 10.1. Endoscopic Mucosal Resection
  • 10.2. Endoscopic Sleeve Gastroplasty
  • 10.3. Endoscopic Submucosal Dissection
  • 10.4. Peroral Endoscopic Myotomy

11. Endoluminal Suturing Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
    • 11.2.1. Academic Hospitals
    • 11.2.2. Community Hospitals
  • 11.3. Specialty Clinics

12. Endoluminal Suturing Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. Value Added Resellers
    • 12.2.2. Wholesalers

13. Endoluminal Suturing Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoluminal Suturing Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoluminal Suturing Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoluminal Suturing Devices Market

17. China Endoluminal Suturing Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Apollo Endosurgery, Inc.
  • 18.6. Aponos Medical LLC
  • 18.7. Becton, Dickinson company
  • 18.8. Boston Scientific Corporation
  • 18.9. Catholic Health Initiatives
  • 18.10. Cook Medical LLC
  • 18.11. EndoTools Therapeutics S.A.
  • 18.12. Fujifilm Holdings Corporation
  • 18.13. HOYA Corporation
  • 18.14. Johnson & Johnson
  • 18.15. KARL STORZ SE & Co. KG
  • 18.16. Medtronic plc
  • 18.17. Olympus Corporation
  • 18.18. Ovesco Endoscopy AG
  • 18.19. STERIS plc
  • 18.20. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISPOSABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISPOSABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISPOSABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY REUSABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY REUSABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY REUSABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC SLEEVE GASTROPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC SLEEVE GASTROPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC SLEEVE GASTROPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PERORAL ENDOSCOPIC MYOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PERORAL ENDOSCOPIC MYOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PERORAL ENDOSCOPIC MYOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ACADEMIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY ACADEMIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY VALUE ADDED RESELLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY VALUE ADDED RESELLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY VALUE ADDED RESELLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY WHOLESALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY WHOLESALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY WHOLESALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ENDOLUMINAL SUTURING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)